Sample policy · Travel clinics

Patient Group Directions and prescribing for travel medicines policy (travel clinics)

Statutory anchor: Regulation 12 (safe care and treatment), Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 (SI 2014/2936). The primary law governing the supply and administration of travel medicines is the Human Medicines Regulations 2012 (Patient Group Directions), read with NICE guidance on PGDs. · primary source

1. What the regulation says

Care and treatment must be provided in a safe way for service users. (Reg 12(1))

assessing the risks to the health and safety of service users of receiving the care or treatment, (Reg 12(2)(a))

doing all that is reasonably practicable to mitigate any such risks, (Reg 12(2)(b))

ensuring that persons providing care or treatment to service users have the qualifications, competence, skills and experience to do so safely, (Reg 12(2)(c))

where equipment or medicines are supplied by the service provider, ensuring that there are sufficient quantities of these to ensure the safety of service users and to meet their needs, (Reg 12(2)(f))

the proper and safe management of medicines, (Reg 12(2)(g))

Regulation 12 lists the areas a provider must address, including risk assessment, risk mitigation, staff competence, safe premises, safe equipment, sufficient equipment and medicines, medicines safety, infection prevention and shared-care planning.

The full text of the regulation is at https://www.legislation.gov.uk/uksi/2014/2936/regulation/12. The Patient Group Directions framework itself sits in the Human Medicines Regulations 2012 at https://www.legislation.gov.uk/uksi/2012/1916/contents. Where this policy and the regulation diverge, the regulation wins.

2. Plain-English summary

Care and treatment must be provided in a safe way. The regulation lists the areas a provider must address, including risk assessment, risk mitigation, staff competence, safe premises, safe equipment, sufficient equipment and medicines, medicines safety, infection prevention and shared-care planning. Regulation 12 is central to CQC's safety expectations. For a travel clinic this means that vaccines and medicines such as antimalarials are supplied or administered only by the right person, under a lawful route (a current Patient Group Direction or a valid prescription), to the right traveller, and properly recorded.

3. Purpose

A travel clinic gives vaccines and supplies medicines such as antimalarials, often through a nurse or pharmacist rather than a doctor. The law sets out exactly how that can be done: many vaccines and medicines are given under a Patient Group Direction (PGD), while prescription-only medicines otherwise need a prescriber. This policy sets out how the Service gives and supplies travel medicines lawfully and safely, so the right person gives the right medicine in the right way.

The Service must verify this policy against the current NICE guidance on Patient Group Directions and the Human Medicines Regulations 2012 before adoption.

4. Scope

This policy applies to:

5. Patient Group Directions

A travel medicine is supplied or administered only under a lawful authority. The options are:

Where the Service uses PGDs:

A practitioner who is asked to act outside a PGD does not stretch the PGD to fit; the situation is referred to a prescriber instead.

6. Prescribing where a PGD does not apply

7. Antimalarials and counselling

Because antimalarials only work if taken correctly, when one is supplied the Service:

8. Unlicensed or off-label use

Where a medicine is used outside its licence (for example a particular antimalarial use), this is recognised, justified against current guidance, explained to the traveller, and recorded. A PGD is not used for an unlicensed medicine unless the conditions that allow it are met.

9. Competency

A practitioner supplies or administers under a PGD, or prescribes, only when trained and assessed as competent for it, and that competence is kept current and refreshed on a stated cadence. The Service records who is authorised for which PGD and the next refresher date.

10. Recording

For every supply or administration the Service records: the medicine, dose and form, the batch number where given, the traveller, the practitioner, and the PGD or prescription it was given under. The record shows the supply was lawful.

Operational controls to adapt

Roles and responsibilities

PGD and prescribing procedure

  1. Keep a live PGD register. Record each PGD, medicine, indication, version, authorising body, start date, review date, expiry date and withdrawal date.
  2. Authorise practitioners by name. A practitioner cannot use a PGD until competence, professional registration and signed authorisation are recorded.
  3. Check the legal route before supply. For each vaccine or medicine, confirm whether the route is a PGD, prescription, Patient Specific Direction, national protocol or another lawful route.
  4. Assess the traveller against the PGD. Check inclusion criteria, exclusions, cautions, interactions, pregnancy or breastfeeding, allergies, age limits and destination risk before supply.
  5. Stop when outside scope. Do not stretch a PGD. Refer to a prescriber, seek advice or decline supply if the traveller falls outside the current terms.
  6. Counsel and record. Explain dose, timing, common side effects, urgent warning signs, bite avoidance where relevant, missed-dose advice and when to seek help.
  7. Control renewal and withdrawal. Expired, superseded or withdrawn PGDs are removed from use and practitioners are told what has changed.
  8. Escalate unsafe medicines events. Wrong medicine, wrong route, expired PGD, unauthorised practitioner, stock concern or missed counselling is opened on the incident register.

Records and register links

The PGD and prescribing record should include:

PGD expiry risk, repeated documentation gaps, out-of-scope requests and practitioner competence gaps are tracked on the risk or improvement-actions register.

11. Audit cadence

The Service checks, on a stated cadence, that:

The Registered Manager and the clinical lead review the results and record the improvement actions that follow.

12. Sources and further reading

This template is based on CQC's guidance for providers and managers, the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, and other topic-specific legislation and guidance listed below. It is a starting point for adaptation, not a substitute for legal, clinical, HR, safeguarding or specialist professional advice.

Related reading

13. When to seek further advice

Seek specialist advice where the issue involves serious harm, safeguarding, deprivation of liberty, restraint, children, professional misconduct, controlled drugs, radiation, termination of pregnancy, infection outbreak, water safety, employment dismissal, DBS barring referral, or regulatory enforcement.

14. Document control

Version Date Author Changes
v1.1 2026-07-14 Verivius (sample) Added role ownership, PGD procedure, legal-authority records, register links and related reading.
v1 2026-06-10 Verivius (sample) Conformed existing draft to the Verivius policy standard. Added statutory anchor, verbatim Regulation 12 text, plain-English summary and standard source/advice/control blocks; all original sections and source URLs preserved.

This sample policy template was issued by Verivius. It is a template, not a substitute for legal advice or the tenant's own policy-development process. Where this template and live law or regulator guidance diverge, the live source wins.

Related Verivius content

Want help adapting this to your service?

A Verivius consultant can read your adapted policy against the live regulation and your service shape. The work fits inside a Mock Inspection engagement or a shorter consulting brief. A 20-minute conversation is the fastest way to find out whether the fit is right.

Get started free

Free to start, no card. A 14-day trial when you subscribe.

Last reviewed 10 June 2026